A randomized, double-blinded, active-controlled multicenter clinical trial to evaluate prophylactic anti-emetic efficacy of ramosetron and ondansetron on post-operative nausea and vomiting in patients with intravenous patient-controlled analgesia

Trial Profile

A randomized, double-blinded, active-controlled multicenter clinical trial to evaluate prophylactic anti-emetic efficacy of ramosetron and ondansetron on post-operative nausea and vomiting in patients with intravenous patient-controlled analgesia

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 May 2017

At a glance

  • Drugs Ramosetron (Primary) ; Ondansetron
  • Indications Postoperative nausea and vomiting
  • Focus Therapeutic Use
  • Acronyms PONV ramosetron
  • Most Recent Events

    • 16 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top